Relafen 750, chemically known as naproxen, embodies a fascinating case study within the biochemical pharmacy field . Its therapeutic effect copyrights on inhibiting cyclooxygenase proteins, specifically COX-1 and COX-2, thereby lessening the production of prostaglandins, which are key mediators of pain and heat. This specific inhibition provides an